SIGNAL // LOADING
Loading page
Provider review required— Compounds on this page are research-grade and dispensed only after eligibility, intake, and licensed provider review. Not FDA approved unless explicitly stated.
Draft preview — not yet clinician-reviewed. Hidden in production.
Tesamorelin
Tesamorelin is a GHRH analog that has received FDA recognition for lipodystrophy and is studied for fat reduct
Tier 1 flagshipGH stimulationProvider reviewWADA-banned
Snapshot
- Visceral fat reduction
- GH stimulation
- Body composition
Purity
>98%
Testing
HPLC, MS
COA
Third-party batch
Format
Lyophilized vial
Overview
Tesamorelin is a GHRH analog that has received FDA recognition for lipodystrophy and is studied for fat reduct
- 01Visceral fat reduction
- 02GH stimulation
- 03Body composition
Purity & quality standards
Minimum purity
>98%
Testing method
HPLC, MS
Certificate of analysis
Third-party batch COA, per lot
Storage
Lyophilized — refrigerate 2–8°C after reconstitution
Eligibility pathway
Licensed provider review required
This compound is WADA-banned and always routes through provider review, regardless of commerce flag.
Pathway logistics
FormatLyophilized vial
CadenceSet by provider
FulfillmentAfter review, mail order
ReviewLicensed provider
EligibilityState-licensed availability
Note:Nothing ships until a licensed provider reviews your intake. If the pathway isn’t right, we say so.
Related compounds
Other peptides clinicians pair with Tesamorelin
Tier 1
BPC-157
BPC-157 is a synthetic peptide derived from a protective protein found in human gastric juice. It has been ext
Tier 1
BPC-157 + TB-500 Blend
Synergistic combination of BPC-157 and TB-500 for comprehensive tissue repair and recovery support.
Tier 1
Cagrilintide
Cagrilintide is a long-acting amylin analog studied for weight management in combination with GLP-1 agonists.
Tier 1
CJC-1295 + Ipamorelin Blend
The gold standard combination of CJC-1295 and Ipamorelin for synergistic growth hormone release.